1. Home
  2. VIV vs NBIX Comparison

VIV vs NBIX Comparison

Compare VIV & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIV
  • NBIX
  • Stock Information
  • Founded
  • VIV 1973
  • NBIX 1992
  • Country
  • VIV Brazil
  • NBIX United States
  • Employees
  • VIV N/A
  • NBIX N/A
  • Industry
  • VIV Telecommunications Equipment
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VIV Telecommunications
  • NBIX Health Care
  • Exchange
  • VIV Nasdaq
  • NBIX Nasdaq
  • Market Cap
  • VIV 14.7B
  • NBIX 11.8B
  • IPO Year
  • VIV 1998
  • NBIX 1996
  • Fundamental
  • Price
  • VIV $8.71
  • NBIX $125.00
  • Analyst Decision
  • VIV Hold
  • NBIX Buy
  • Analyst Count
  • VIV 3
  • NBIX 24
  • Target Price
  • VIV $10.97
  • NBIX $163.91
  • AVG Volume (30 Days)
  • VIV 711.3K
  • NBIX 1.1M
  • Earning Date
  • VIV 11-05-2024
  • NBIX 10-30-2024
  • Dividend Yield
  • VIV 5.97%
  • NBIX N/A
  • EPS Growth
  • VIV 19.08
  • NBIX 97.40
  • EPS
  • VIV 0.60
  • NBIX 3.73
  • Revenue
  • VIV $10,063,607,239.00
  • NBIX $2,242,800,000.00
  • Revenue This Year
  • VIV $9.64
  • NBIX $26.97
  • Revenue Next Year
  • VIV $5.51
  • NBIX $16.69
  • P/E Ratio
  • VIV $14.92
  • NBIX $33.47
  • Revenue Growth
  • VIV 6.98
  • NBIX 25.72
  • 52 Week Low
  • VIV $8.02
  • NBIX $110.52
  • 52 Week High
  • VIV $11.43
  • NBIX $157.98
  • Technical
  • Relative Strength Index (RSI)
  • VIV 34.21
  • NBIX 57.39
  • Support Level
  • VIV $8.92
  • NBIX $115.27
  • Resistance Level
  • VIV $9.07
  • NBIX $129.67
  • Average True Range (ATR)
  • VIV 0.16
  • NBIX 3.37
  • MACD
  • VIV -0.01
  • NBIX -0.09
  • Stochastic Oscillator
  • VIV 5.33
  • NBIX 67.57

About VIV Telefonica Brasil S.A. (Each representing One Common Share)

Telefonica Brasil, known as Vivo, is the largest wireless carrier in Brazil with 100 million customers, which is equal to about 39% market share. The firm is strongest in the postpaid business, where it has 65 million customers, or about 41% share of this market. Wireless services and equipment contribute about 70% of total revenue. Vivo is the incumbent fixed-line telephone operator in Sao Paulo state and, following the acquisition of GVT, the owner of an extensive fiber network across the country. The firm provides internet access to 7 million households on this network. The firm also sells pay-tv and phone services to its fixed-line customers. Finally, corporate data and IT services, including cloud computing support, contribute about 8% of total revenue.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Share on Social Networks: